- Home
- GRAF vs IMMP Comparison
GRAF vs IMMP Comparison
Compare GRAF & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAF
- IMMP
- Stock Information
- Founded
- GRAF 2021
- IMMP 1987
- Country
- GRAF United States
- IMMP Australia
- Employees
- GRAF N/A
- IMMP N/A
- Industry
- GRAF
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- GRAF
- IMMP Health Care
- Exchange
- GRAF NYSE
- IMMP Nasdaq
- Market Cap
- GRAF 288.1M
- IMMP 264.7M
- IPO Year
- GRAF 2024
- IMMP N/A
- Fundamental
- Price
- GRAF $10.02
- IMMP $1.85
- Analyst Decision
- GRAF
- IMMP Buy
- Analyst Count
- GRAF 0
- IMMP 2
- Target Price
- GRAF N/A
- IMMP $8.50
- AVG Volume (30 Days)
- GRAF 24.9K
- IMMP 115.6K
- Earning Date
- GRAF 01-01-0001
- IMMP 11-26-2024
- Dividend Yield
- GRAF N/A
- IMMP N/A
- EPS Growth
- GRAF N/A
- IMMP N/A
- EPS
- GRAF 0.25
- IMMP N/A
- Revenue
- GRAF N/A
- IMMP $2,563,302.00
- Revenue This Year
- GRAF N/A
- IMMP N/A
- Revenue Next Year
- GRAF N/A
- IMMP $10.84
- P/E Ratio
- GRAF $40.39
- IMMP N/A
- Revenue Growth
- GRAF N/A
- IMMP 9.59
- 52 Week Low
- GRAF $9.03
- IMMP $1.66
- 52 Week High
- GRAF $11.02
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- GRAF N/A
- IMMP 43.26
- Support Level
- GRAF N/A
- IMMP $1.91
- Resistance Level
- GRAF N/A
- IMMP $2.07
- Average True Range (ATR)
- GRAF 0.00
- IMMP 0.10
- MACD
- GRAF 0.00
- IMMP 0.01
- Stochastic Oscillator
- GRAF 0.00
- IMMP 25.00
About GRAF GRAF GLOBAL CORP
Graf Global Corp is a blank check company.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.